How Was Korea Different In Handling COVID-19 Situation?
Local R&D Making Progress
Executive Summary
South Korea authorities talk to foreign media about the country's experience and successes in dealing with the COVID-19 situation, progress in drug and vaccine development, lessons learned and the preparations being made to return to everyday life.
You may also be interested in...
APAC Podcast: Virus Industry Impact, China Vaccines, Remdesivir Deals, Korea SitRep
Join the Pink Sheet and Scrip's Asia content team for a wide-ranging look at the ongoing multiple impacts of the pandemic on the pharma industry.
APAC Podcast: Virus Industry Impact, China Vaccines, Remdesivir Deals, Korea SitRep
Join Scrip and the Pink Sheet’s Asia content team for a wide-ranging look at the ongoing multiple impacts of the pandemic on the pharma industry.
GC Pharma Aiming To Outrun Rivals For COVID-19 Plasma Therapy
A South Korean pharma firm is set to soon begin pivotal clinical trials for a hyperimmune globulin for the treatment of COVID-19 patients and plans to commercialize the product this year, with a hope of outrunning rivals including Takeda.